Complete Genome Sequences of Four Mycobacteriophages Involved in Directed Evolution against Undisputed Mycobacterium abscessus Clinical Strains

Juan Carlos Cao Yao,Damir Garcia Cehic,Josep Quer,Jesús Navas Méndez,Alexis Dorta Gorrín,Lorena García Hevia,María Teresa Tórtola Fernández
DOI: https://doi.org/10.3390/microorganisms12020374
IF: 4.5
2024-02-11
Microorganisms
Abstract:Phage therapy is still in its infancy, but it is increasingly promising as a future alternative for treating antibiotic-resistant bacteria. To investigate the effect of phages on Mycobacterium abscessus complex (MABC), we isolated 113 environmental phages, grown them to high titres, and assayed them on MABC clinical strains through the spot test. Of all the phages, only 16 showed killing activity. Their activity was so temperate to MABC that they could not generate any plaque-forming units (PFUs). The Appelmans method of directed evolution was carried out to evolve these 16 phages into more lytic ones. After only 11 of 30 rounds of evolution, every single clinical strain in our collection, including those that were unsusceptible up to this point, could be lysed by at least one phage. The evolved phages were able to form PFUs on the clinical strains tested. Still, they are temperate at best and require further training. The genomes of one random parental phage and three random evolved phages from Round 13 were sequenced, revealing a diversity of clusters and genes of a variety of evolutionary origins, mostly of unknown function. These complete annotated genomes will be key for future molecular characterisations.
microbiology
What problem does this paper attempt to address?
This paper mainly discusses the application of phage therapy as an alternative therapy for drug-resistant bacteria in complex clinical strains of Mycobacterium abscessus. The researchers screened 113 phages from the environment and evaluated their bactericidal activity against Mycobacterium abscessus through spot tests. Among all the phages, only 16 showed bactericidal activity, but they exhibited mildness and were unable to form plaques on Mycobacterium abscessus. Through Appelman's directed evolution method, these phages were evolved into more lytic forms. After 11 rounds of evolution, all clinical strains could be lysed by at least one phage. Further genomic sequencing revealed the diversity and different evolutionary origins of these phages, providing critical information for future molecular characterization. The study also emphasizes the importance of phage therapy in combating antibiotic-resistant bacteria worldwide and provides multiple successful cases, including the treatment of Mycobacterium abscessus and other bacterial infections. Despite the success of phage therapy in some cases, there have also been failures, indicating the necessity of individualization and continuous optimization of phage treatment methods. Lastly, the paper discusses the genomic characteristics of phages, the principles of directed evolution, and the broad applications of this method in biotechnology.